Drugs News and Research

RSS

Hydrus stent may significantly reduce eye pressure in glaucoma patients

A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to year-one clinical trial results for the device.

14 Nov 2012

Heart attack centres play a vital role in saving patients’ lives

Recent studies questioning the role of specialist heart attack centres produced misleading results because doctors tend to send the sickest patients to have the best care, according to new research.

14 Nov 2012

Scientists to develop hydrogels that can be injected into patients to form active biological scaffolds

Smart scaffolding that can guide cells, proteins and small-molecule drugs to make new tissue and repair damage inside the body is in the works at Rice University.

14 Nov 2012

EpiCept third quarter revenue increases to $0.9 million

EpiCept Corporation today reported a net loss for the three months ended September 30, 2012 of $1.1 million and a net loss for the nine months ended September 30, 2012 of $1.7 million.

14 Nov 2012

Insurance roundup: U.S. overpaying nursing homes; Deductibles rising; 'Carrots and sticks' health plans

News outlets cover various aspects of the costs of coverage, including in Medicare, high-deductible plans and also in the average employee plan.

14 Nov 2012

Gene variants involved in glutamatergic transmission appear to increase risk of depression

Researchers using a new approach to identifying genes associated with depression have found that variants in a group of genes involved in transmission of signals by the neurotransmitter glutamate appear to increase the risk of depression.

14 Nov 2012

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

Ligand Pharmaceuticals Incorporated announced that data from preclinical studies evaluating LG-7501 were featured in a poster presentation today at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston.

14 Nov 2012

Study finds several osteoporosis risk factors among post-menopausal women on HRT

A preliminary study of 127 post-menopausal women on hormone replacement therapy in Portugal suggests that there are several risk factors associated with osteoporosis and bone fracture these include age, low bone mineral density, a sedentary lifestyle, coffee consumption and ovariectomy. Details are reported later this month in the International Journal of Medical Engineering and Informatics.

14 Nov 2012

Malaria Box helps identify three chemical series that target treatment of NTDs

The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.

14 Nov 2012

Tiltan Pharma initiates enrollment in TL-118 Phase 2 trial for metastatic pancreatic cancer

Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer.

14 Nov 2012

Reflexology can help cancer patients manage their symptoms and perform daily tasks

A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology - a type of specialized foot massage practiced since the age of pharaohs - can help cancer patients manage their symptoms and perform daily tasks.

14 Nov 2012

Scientists discover how external signals regulate vascular remodelling at cell level

Blood vessels are extremely dynamic: depending on the external conditions, they can adapt their permeability for nutrients, their contractility, and even their shape. Unlike cardiac muscle cells, for example, the smooth muscle cells in blood vessels demonstrate a high degree of plasticity, so they can specialise or multiply as required, even repairing damage to the vessel wall.

13 Nov 2012

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Implantable defibrillators currently on the market apply between 600 and 900 volts to the heart, almost 10 times the voltage from an electric outlet, says Ajit H. Janardhan, MD, PhD, a cardiac electrophysiology fellow at the Washington University's School of Medicine.

13 Nov 2012

Caution over monoclonal antibody treatment for MS

Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.

12 Nov 2012

TRILOGY-ACS platelet function substudy results revealed

The platelet function substudy of the TRILOGY-ACS trial shows that there is no significant difference between prasugrel and clopidogrel in cardiovascular mortality, myocardial infarction, or stroke outcomes.

12 Nov 2012

Auto-injector developed for women undergoing fertility treatment

A new auto-injector concept has been designed by innovative product development firm Cambridge Consultants in a bid to ease the trauma for women undergoing fertility treatment.

12 Nov 2012

Addiction counselors tolerate moderate substance abuse in patients

Nearly half of alcohol and drug addiction counselors now find it acceptable for their patients to drink or take drugs occasionally, a survey has found.

9 Nov 2012

New vaccines and drug treatments urgently needed for bacterial meningitis

New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial meningitis, published in The Lancet.

9 Nov 2012

Patients more likely to develop ischemic stroke after total hip replacement surgeries

An international study involving the University of Southampton has shown people who undergo a total hip replacement are at a higher risk of a stroke in the first two weeks after surgery.

9 Nov 2012

IPS examines generic drug scheme in India's Rajasthan state

"As the northern Indian state of Rajasthan rolls out an ambitious universal health care plan, the discontent of the state's doctors stands in stark contrast to the joys of the 68 million people who will benefit from the scheme," Inter Press Service reports.

9 Nov 2012

Drugs News and Research

Hydrus stent may significantly reduce eye pressure in glaucoma patients

Heart attack centres play a vital role in saving patients’ lives

Scientists to develop hydrogels that can be injected into patients to form active biological scaffolds

EpiCept third quarter revenue increases to $0.9 million

Insurance roundup: U.S. overpaying nursing homes; Deductibles rising; 'Carrots and sticks' health plans

Gene variants involved in glutamatergic transmission appear to increase risk of depression

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

Study finds several osteoporosis risk factors among post-menopausal women on HRT

Malaria Box helps identify three chemical series that target treatment of NTDs

Tiltan Pharma initiates enrollment in TL-118 Phase 2 trial for metastatic pancreatic cancer

Reflexology can help cancer patients manage their symptoms and perform daily tasks

Scientists discover how external signals regulate vascular remodelling at cell level

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Caution over monoclonal antibody treatment for MS

TRILOGY-ACS platelet function substudy results revealed

Auto-injector developed for women undergoing fertility treatment

Addiction counselors tolerate moderate substance abuse in patients

New vaccines and drug treatments urgently needed for bacterial meningitis

Patients more likely to develop ischemic stroke after total hip replacement surgeries

IPS examines generic drug scheme in India's Rajasthan state

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News